Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
CERo Therapeutics Holdings, Inc. - Common Stock
(NQ:
CERO
)
0.1828
-0.0732 (-28.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CERo Therapeutics Holdings, Inc. - Common Stock
< Previous
1
2
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 08, 2024
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 07, 2024
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via
Benzinga
Dow Gains 100 Points; Victoria's Secret Shares Plunge
March 07, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 1% on Thursday. The Dow traded up 0.26% to 38,762.00 while the NASDAQ rose 1.38% to 16,253.50. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why CERo Therapeutics Stock Is Soaring
March 07, 2024
CERo Therapeutics shares are racing higher Thursday after the company announced the publication of preclinical research on the use of its clinical candidate CER-1236 to treat AML patients.The...
Via
Benzinga
Nasdaq Rises 100 Points; BJ's Wholesale Posts Weak Sales
March 07, 2024
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.47% to 38,843.54 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients
March 07, 2024
From
CERo Therapeutics Holdings, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.